AstraZeneca PLC (AZN)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

11,276.00p

Buy

11,280.00p

arrow-up30.00p (+0.27%)

Prices updated at 23 Apr 2024, 09:00 BST
| Prices minimum 15 mins delay
|
Prices in GBX
AstraZeneca PLC belongs to the healthcare sector. The company develops and markets pharmaceutical products for various therapeutic classes such as gastrointestinal, cardiovascular, respiratory, cancer, immunology, and neuroscience.
FTSE All-Share
arrow-up0.44%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - General
Chairman
Mr. Michel Demare
CEO
Mr. Pascal Soriot
Most recent earnings
31 Dec 2023
Fiscal year end
31 Dec 2023
Employees
89,900
Head office
1 Francis Crick Avenue
Cambridge
United Kingdom
CB2 0AA
mobile
+44 2037495000
letter
ir@astrazeneca.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Philip A J Broadley
Non-Executive Director, Senior Independent Director
-
Mr. Michel Demare
Non-Executive Director, Chairman
-
Ms. Sherilyn D. McCoy
Non-Executive Director
-
Dr. Andreas Rummelt
Non-Executive Director
-
Mr. Marcus Wallenberg
Non-Executive Director
-
Ms. Diana Layfield
Non-Executive Director
-
Ms. Deborah DiSanzo
Non-Executive Director
-
Ms. Anna Olive Magdelene Manz
Non-Executive Director
-
Professor Nazneen Rahman
Non-Executive Director
-
Professor Tony Mok
Non-Executive Director
-
Dr. Euan Ashley
Non-Executive Director
-
Dr. Aradhana Sarin
Executive Director, Chief Financial Officer
-
Mr. Pascal Soriot
Executive Director, Chief Executive Officer
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Capital Research and Management Company83,002,852
Capital Group44,046,324
Vanguard Group Inc40,987,139
BlackRock Fund Advisors25,864,513
BlackRock Investment Management (UK) Ltd.24,474,644

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
08 Mar 2024Transfer in
05 Mar 2024Transfer in
20 Feb 2024Transfer in
12 Dec 2023Purchase
22 Nov 2023Purchase
21 Nov 2023Purchase
05 May 2023Sale
28 Apr 2023Purchase
Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.